Generation Bio to Present at Jefferies 2019 Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Generation Bio, a company developing the first genetic medicines that can be re-dosed and titrated to effect for a lifetime of benefit, today announced that President and Chief Executive Officer, Geoff McDonough, will present a company update at the Jefferies 2019 Healthcare Conference in New York, NY. The presentation will take place at 10:30 a.m. ET on Thursday, June 6.

To access a live webcast and archived recording of the presentation, please visit the “News” section on the Generation Bio website at www.generationbio.com/news/.

About Generation Bio
Generation Bio is a biotechnology company developing a breakthrough class of genetic medicines to enable a new generation of people to live unaffected by inherited disease. The company is using its proprietary ceDNA platform to create gene therapies with drug-like properties – delivering durable gene expression with the ability to re-dose for individual patient titration and for the potential to sustain effect over a lifetime. Generation Bio was founded and launched by Atlas Venture and is headquartered in Cambridge, Mass. For more information, please visit www.generationbio.com or follow @generationbio.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190531005045/en/

Investor contacts:
Lauren Stival and Naina Zaman
Stern Investor Relations
(212) 362-1200
[email protected]

Media Contact:
Max Stendahl
Ten Bridge Communications
(508) 277-8117
[email protected]

Source: Generation Bio

You May Also Be Interested In

• Bark Inc. (BARK) PT Raised to $19 at Jefferies Following 20:1 Reverse Split
• Shiba Inu Price Prediction: SHIB Whales Go Quiet While AlphaPepe Turns AlphaSwap Into the Louder Catalyst
• Autolus Therapeutics Receives Prix Galien UK Award